Melodic Intonation Therapy

Melodic intonation therapy (MIT) is covered as medically necessary only for Broca’s (nonfluent/expressive) aphasia when ALL selection criteria are met—good auditory comprehension and span, motivated/emotionally stable, poor repetition (even single words), no bilateral brain involvement, and nonfluent speech with diminished articulator agility and effortful initiation (ICD‑10: I69.020/I69.120/I69.220/I69.320/I69.820/I69.920, R47.01). MIT is not covered (considered experimental/investigational) for dysarthria, verbal apraxia, other aphasia types, voice/singing feminization, combined use with brain stimulation (tDCS/rTMS), or any indications not explicitly listed as covered.

"Selection criterion: There is no evidence of bilateral brain involvement"

Sign up to see full coverage criteria, indications, and limitations.